title: Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.
abstract: To elucidate potential causes for differing bleeding phenotypes of haemophilic patients of identical degree of coagulation factor deficiency, we investigated 21 male patients with severe haemophilia. Median annual coagulation factor demand and the extent of haemophilic arthropathy were used to discriminate between intensely and less intensely haemorrhagic phenotypes. Haemophiliacs with a median annual coagulation factor demand of 800 IU per kg bodyweight or more and with three or more joints affected by haemophilic arthropathy represented the intensely haemorrhagic phenotype group; all other patients comprised the less intense group. The discriminator values represent the respective medians of the overall group. The results of activated partial thromboplastin time, endogenous thrombin potential, pro- and anticoagulant factor analysis did not differ between the two groups. Median tissue-type plasminogen activator concentration (TPA) was elevated significantly in haemophiliacs with an intensely haemorrhagic phenotype, as was the activity of the thrombin-activatable fibrinolysis inhibitor. Median activity of the plasminogen activator inhibitor 1 (PAI 1) and the concentration of TPA-PAI 1 complexes were increased to approximately double those in nonsevere haemophiliacs. Coexistent congenital thrombophilia was found significantly more often in the less intensely haemorrhagic group. Thus, increased stimulation of the fibrinolytic system was associated with a more intensely haemorrhagic phenotype in our patients. We hypothesize that ineffective haemophilic haemostasis in response to trauma evokes a protracted stimulation of the entire haemostatic system, including costimulation of fibrinolysis. The absence of coexistent congenital thrombophilia predisposes to excess stimulation of fibrinolysis, which cannot be downregulated effectively due to the dysfunctional intrinsic pathway. The association of a more intensely haemorrhagic phenotype with a paradoxical hyperstimulation of the fibrinolytic system resembles a vicious circle, where bleeding seems to cause predisposition to more bleeding.
authors.affiliation: Department of Haematology, Haemostaseology Division, University of Ulm, Germany. martin.gruenewald@medizin.uni-ulm.de
authors.forename: M
authors.initials: M
authors.lastname: Grünewald
authors.forename: A
authors.initials: A
authors.lastname: Siegemund
authors.forename: A
authors.initials: A
authors.lastname: Grünewald
authors.forename: A
authors.initials: A
authors.lastname: Konegan
authors.forename: M
authors.initials: M
authors.lastname: Koksch
authors.forename: M
authors.initials: M
authors.lastname: Griesshammer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001779:Blood Coagulation Factors / Q000032:analysis; D004334:Drug Administration Schedule; D005164:Factor IX / Q000008:administration & dosage; D005169:Factor VIII / Q000008:administration & dosage; D005342:Fibrinolysis; D006395:Hemarthrosis / Q000097:blood; D006467:Hemophilia A / Q000097:blood* / Q000150:complications; D002836:Hemophilia B / Q000097:blood* / Q000150:complications; D006470:Hemorrhage / Q000097:blood* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D019851:Thrombophilia / Q000150:complications; D010959:Tissue Plasminogen Activator / Q000032:analysis
chemical_list: D001779:Blood Coagulation Factors; D005169:Factor VIII; D005164:Factor IX; D010959:Tissue Plasminogen Activator